Paloma Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,600
Closed -$1.95M 779
2022
Q4
$1.95M Buy
11,600
+5,700
+97% +$991K 0.09% 229
2022
Q3
$1.04M Buy
+5,900
New +$1.17M 0.05% 316
2022
Q2
Sell
-7,100
Closed -$1.69M 1209
2022
Q1
$1.69M Buy
+7,100
New +$1.67M 0.05% 286
2021
Q4
Sell
-13,200
Closed -$2.55M 1919
2021
Q3
$2.55M Buy
+13,200
New +$2.67M 0.06% 189
2020
Q4
Sell
-6,800
Closed -$1.14M 1721
2020
Q3
$1.14M Sell
6,800
-3,100
-31% -$522K 0.03% 664
2020
Q2
$1.61M Buy
+9,900
New +$1.77M 0.03% 706
2019
Q3
Sell
-3,900
Closed -$757K 2002
2019
Q2
$757K Buy
+3,900
New +$719K 0.01% 832
2017
Q4
Sell
-21,700
Closed -$2.94M 1928
2017
Q3
$2.94M Buy
21,700
+3,500
+19% +$442K 0.04% 507
2017
Q2
$2.28M Hold
18,200
0.03% 672
2017
Q1
$2.16M Buy
+18,200
New +$2.19M 0.03% 736
2016
Q4
Sell
-8,000
Closed -$836K 1992
2016
Q3
$836K Sell
8,000
-16,000
-67% -$1.67M 0.01% 1142
2016
Q2
$2.34M Buy
24,000
+8,000
+50% +$756K 0.03% 638
2016
Q1
$1.54M Buy
16,000
+8,000
+100% +$728K 0.03% 613
2015
Q4
$725K Hold
8,000
0.02% 823
2015
Q3
$742K Buy
+8,000
New +$760K 0.02% 815

Other funds holding CME

Paloma Partners's CME Position: Q3 2024 in Review

Paloma Partners sold out of CME Group (CME) in Q3 2024, closing a stake of 4,351 shares — an estimated $855K sold.

Paloma Partners first reported a position in CME in Q2 2013 and held it in 31 quarters. The position peaked at $23.3M in Q1 2016. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • Paloma Partners reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 4,351 CME Group shares in Q3 2024, an estimated $855K.
  • Paloma Partners first reported a position in CME Group in Q2 2013 and held it in 31 quarters.
  • Paloma Partners's CME Group position peaked at $23.3M in Q1 2016.
  • 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.